Pathobiology

Original Paper

Free Access

Human Papillomavirus Epitope Mimicry and Autoimmunity: The Molecular Truth of Peptide Sharing

Kanduc D.a · Shoenfeld Y.b,c

Author affiliations

aDepartment of Biosciences, Biotechnologies, and Biopharmaceutics, University of Bari, Bari, Italy
bZabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Tel-Aviv, University School of Medicine, Ramat Gan, Israel
cI.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian, Federation, Sechenov University, Moscow, Russian Federation

Corresponding Author

Darja Kanduc

Department of Biosciences, Biotechnologies and Biopharmaceutics

University of Bari

Via Orabona 4, IT–70125 Bari (Italy)

E-Mail dkanduc@gmail.com

Related Articles for ""

Pathobiology 2019;86:285–295

Abstract

Objective: To define the cross-reactivity potential and the consequent autoimmunity intrinsic to viral versus human peptide sharing. Methods: Using human papillomavirus (HPV) infection/active immunization as a research model, the experimentally validated HPV L1 epitopes catalogued at the Immune Epitope DataBase were analyzed for peptide sharing with the human proteome. Results: The final data show that the totality of the immunoreactive HPV L1 epi­topes is mostly composed by peptides present in human proteins. Conclusions: Immunologically, the high extent of peptide sharing between the HPV L1 epitopes and human proteins invites to revise the concept of the negative selection of self-reactive lymphocytes. Pathologically, the data highlight a cross-reactive potential for a spectrum of autoimmune diseases that includes ovarian failure, systemic lupus erythematosus (SLE), breast cancer and sudden death, among others. Therapeutically, analyzing already validated immunoreactive epitopes filters out the peptide sharing possibly exempt of self-reactivity, defines the effective potential for pathologic autoimmunity, and allows singling out peptide epitopes for safe immunotherapeutic protocols.

© 2019 S. Karger AG, Basel




Related Articles:


References

  1. Janeway CA Jr., Travers P, Walport M, Shlomchik MJ: Immunobiology: The Immune System in Health and Disease. New York: Garland Science; 2001.
  2. Nielsen PR, Kragstrup TW, Deleuran BW, Benros ME. Infections as risk factor for autoimmune diseases - A nationwide study. J Autoimmun. 2016 Nov;74:176–81.
  3. Honkanen H, Oikarinen S, Nurminen N, Laitinen OH, Huhtala H, Lehtonen J, et al. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia. 2017 Mar;60(3):424–31.
  4. Sakkas LI, Daoussis D, Liossis SN, Bogdanos DP. The infectious basis of ACPA-positive rheumatoid arthritis. Front Microbiol. 2017 Sep;8:1853.
  5. Alaedini A, Lebwohl B, Wormser GP, Green PH, Ludvigsson JF. Borrelia infection and risk of celiac disease. BMC Med. 2017 Sep;15(1):169.
  6. Blackmore S, Hernandez J, Juda M, Ryder E, Freund GG, Johnson RW, et al. Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2017 Jul;114(30):E6107–16.
  7. Kemppainen KM, Lynch KF, Liu E, Lönnrot M, Simell V, Briese T, et al.; TEDDY Study Group. Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life. Clin Gastroenterol Hepatol. 2017 May;15(5):694–702.e5.
  8. Mustonen N, Siljander H, Peet A, Tillmann V, Härkönen T, Ilonen J, et al.; DIABIMMUNE Study Group. Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk. Pediatr Diabetes. 2018 Mar;19(2):293–9.
  9. Burgueño-Montañés C, Álvarez-Coronado M, Colunga-Cueva M. Autoimmune neuroretinopathy secondary to Zika virus infection. Arch Soc Esp Oftalmol. 2018 Jul;93(7):336–41.
  10. Fujinami RS, Oldstone MB, Wroblewska Z, Frankel ME, Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA. 1983 Apr;80(8):2346–50.
  11. Oldstone MB. Molecular mimicry: its evolution from concept to mechanism as a cause of autoimmune diseases. Monoclon Antib Immunodiagn Immunother. 2014 Jun;33(3):158–65.
  12. Natale C, Giannini T, Lucchese A, Kanduc D. Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunol Cell Biol. 2000 Dec;78(6):580–5.
  13. Kanduc D, Stufano A, Lucchese G, Kusalik A. Massive peptide sharing between viral and human proteomes. Peptides. 2008 Oct;29(10):1755–66.
  14. Trost B, Lucchese G, Stufano A, Bickis M, Kusalik A, Kanduc D. No human protein is exempt from bacterial motifs, not even one. Self Nonself. 2010 Oct;1(4):328–34.
  15. Lucchese G, Capone G, Kanduc D. Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins. Schizophr Bull. 2014 Mar;40(2):362–75.
  16. Lucchese G. Understanding neuropsychiatric diseases, analyzing the peptide sharing between infectious agents and the language-associated NMDA 2A protein. Front Psychiatry. 2016 Apr;7:60.
  17. Lucchese G. From toxoplasmosis to schizophrenia via NMDA dysfunction: peptide overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors as a potential mechanistic link. Front Psychiatry. 2017 Mar;8:37.
  18. Kanduc D, Shoenfeld Y. Inter-pathogen peptide sharing and the original antigenic sin: solving a paradox. Open Immunol J. 2018;8(1):11–27.
    External Resources
  19. Cohn M. Two unresolved problems facing models of the Self-Nonself discrimination. J Theor Biol. 2015 Dec;387:31–8.
  20. Rose NR. Negative selection, epitope mimicry and autoimmunity. Curr Opin Immunol. 2017 Dec;49:51–5.
  21. Reddehase MJ, Rothbard JB, Koszinowski UH. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature. 1989 Feb;337(6208):651–3.
  22. Zeng W, Pagnon J, Jackson DC. The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function. Mol Immunol. 2007 Jul;44(15):3724–31.
  23. Kanduc D. Homology, similarity, and identity in peptide epitope immunodefinition. J Pept Sci. 2012 Aug;18(8):487–94.
  24. Kanduc D. Pentapeptides as minimal functional units in cell biology and immunology. Curr Protein Pept Sci. 2013 Mar;14(2):111–20.
  25. Hao SS, Zong MM, Zhang Z, Cai JX, Zheng Y, Feng XL, et al. The inducing roles of the new isolated bursal hexapeptide and pentapeptide on the immune response of AIV vaccine in mice. Protein Pept Lett. 2019;26(7):542–9.
  26. Godi A, Facchetti A, Bissett SL, Cocuzza C, Miller E, Beddows S. Naturally occurring major and minor capsid protein variants of Human Papillomavirus 45 (HPV45): differential recognition by cross-neutralizing antibodies generated by HPV vaccines. J Virol. 2015 Dec;90(6):3247–52.
  27. Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, et al. The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res. 2019 Jan;47(D1):D339–43.
  28. Chen C, Li Z, Huang H, Suzek BE, Wu CH; UniProt Consortium. A fast Peptide Match service for UniProt Knowledgebase. Bioinformatics. 2013 Nov;29(21):2808–9.
  29. UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan;47(D1):D506–15.
  30. Kanduc D. The comparative biochemistry of viruses and humans: an evolutionary path towards autoimmunity. Biol Chem. 2019 Apr;400(5):629–38.
  31. Wood-Trageser MA, Gurbuz F, Yatsenko SA, Jeffries EP, Kotan LD, Surti U, et al. MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability. Am J Hum Genet. 2014 Dec;95(6):754–62.
  32. Guo H, Zhu P, Yan L, Li R, Hu B, Lian Y, et al. The DNA methylation landscape of human early embryos. Nature. 2014 Jul;511(7511):606–10.
  33. Andreu-Vieyra CV, Chen R, Agno JE, Glaser S, Anastassiadis K, Stewart AF, et al. MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing. PLoS Biol. 2010 Aug;8(8):e1000453.
  34. Morimoto A, Shibuya H, Zhu X, Kim J, Ishiguro K, Han M, et al. A conserved KASH domain protein associates with telomeres, SUN1, and dynactin during mammalian meiosis. J Cell Biol. 2012 Jul;198(2):165–72.
  35. Mizusawa Y, Kuji N, Tanaka Y, Tanaka M, Ikeda E, Komatsu S, et al. Expression of human oocyte-specific linker histone protein and its incorporation into sperm chromatin during fertilization. Fertil Steril. 2010 Mar;93(4):1134–41.
  36. Bione S, Sala C, Manzini C, Arrigo G, Zuffardi O, Banfi S, et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet. 1998 Mar;62(3):533–41.
  37. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003 May;72(5):1117–30.
  38. Jääskeläinen M, Nieminen A, Pökkylä RM, Kauppinen M, Liakka A, Heikinheimo M, et al. Regulation of cell death in human fetal and adult ovaries—role of Bok and Bcl-X(L). Mol Cell Endocrinol. 2010 Dec;330(1-2):17–24.
  39. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet. 2004 Jul;75(1):106–11.
  40. Kasippillai T, MacArthur DG, Kirby A, Thomas B, Lambalk CB, Daly MJ, et al. Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency. J Clin Endocrinol Metab. 2013 Sep;98(9):E1534–9.
  41. Martins da Silva SJ, Bayne RA, Cambray N, Hartley PS, McNeilly AS, Anderson RA. Expression of activin subunits and receptors in the developing human ovary: activin A promotes germ cell survival and proliferation before primordial follicle formation. Dev Biol. 2004 Feb;266(2):334–45.
  42. Dam AH, Koscinski I, Kremer JA, Moutou C, Jaeger AS, Oudakker AR, et al. Homozygous mutation in SPATA16 is associated with male infertility in human globozoospermia. Am J Hum Genet. 2007 Oct;81(4):813–20.
  43. Yan W, Ma L, Burns KH, Matzuk MM. HILS1 is a spermatid-specific linker histone H1-like protein implicated in chromatin remodeling during mammalian spermiogenesis. Proc Natl Acad Sci USA. 2003 Sep;100(18):10546–51.
  44. Matsuoka Y, Miyagawa Y, Tokuhiro K, Kitamura K, Iguchi N, Maekawa M, et al. Isolation and characterization of the spermatid-specific Smrp1 gene encoding a novel manchette protein. Mol Reprod Dev. 2008 Jun;75(6):967–75.
  45. Lehti MS, Henriksson H, Rummukainen P, Wang F, Uusitalo-Kylmälä L, Kiviranta R, et al. Cilia-related protein SPEF2 regulates osteoblast differentiation. Sci Rep. 2018 Jan;8(1):859.
  46. Yang YR, Kang DS, Lee C, Seok H, Follo MY, Cocco L, et al. Primary phospholipase C and brain disorders. Adv Biol Regul. 2016 May;61:80–5.
  47. Pang JC, Dong Z, Zhang R, Liu Y, Zhou LF, Chan BW, et al. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors. Int J Cancer. 2003 May;105(1):76–81.
  48. Andries V, Vandepoele K, Staes K, Berx G, Bogaert P, Van Isterdael G, et al. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest. BMC Cancer. 2015 May;15(1):391.
  49. Kehrer-Sawatzki H, Cooper DN. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes? J Med Genet. 2008 Oct;45(10):622–31.
  50. Kim YO, Nam TS, Park C, Kim SK, Yoon W, Choi SY, et al. Familial pachygyria in both genders related to a DCX mutation. Brain Dev. 2016 Jun;38(6):585–9.
  51. Maliniemi P, Carlsson E, Kaukola A, Ovaska K, Niiranen K, Saksela O, et al. NAV3 copy number changes and target genes in basal and squamous cell cancers. Exp Dermatol. 2011 Nov;20(11):926–31.
  52. Silva JP, Lelianova VG, Ermolyuk YS, Vysokov N, Hitchen PG, Berninghausen O, et al. Latrophilin 1 and its endogenous ligand Lasso/teneurin-2 form a high-affinity transsynaptic receptor pair with signaling capabilities. Proc Natl Acad Sci USA. 2011 Jul;108(29):12113–8.
  53. Li J, Shalev-Benami M, Sando R, Jiang X, Kibrom A, Wang J, et al. Structural basis for teneurin function in circuit-wiring: a toxin motif at the synapse. Cell. 2018 Apr;173(3):735–748.e15.
  54. Ferralli J, Tucker RP, Chiquet-Ehrismann R. The teneurin C-terminal domain possesses nuclease activity and is apoptogenic. Biol Open. 2018 Mar;7(3):bio031765.
  55. Graumann R, Di Capua GA, Oyarzún JE, Vásquez MA, Liao C, Brañes JA, et al. Expression of teneurins is associated with tumor differentiation and patient survival in ovarian cancer. PLoS One. 2017 May;12(5):e0177244.
  56. Tsokos GC, Gordon C, Smolen JS, editors. Systemic Lupus Erythematosus: a Companion to Rheumatology. Philadelphia: Mosby Elsevier; 2007.
  57. Wang B, Shao X, Wang D, Xu D, Zhang JA. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis. Autoimmun Rev. 2017 Jul;16(7):756–65.
  58. Garg M, Mufti N, Palmore TN, Hasni SA. Recommendations and barriers to vaccination in systemic lupus erythematosus. Autoimmun Rev. 2018 Oct;17(10):990–1001.
  59. Tayebati SK, Lokhandwala MF, Amenta F. Dopamine and vascular dynamics control: present status and future perspectives. Curr Neurovasc Res. 2011 Aug;8(3):246–57.
  60. Martikainen IK, Hagelberg N, Jääskeläinen SK, Hietala J, Pertovaara A. Dopaminergic and serotonergic mechanisms in the modulation of pain: in vivo studies in human brain. Eur J Pharmacol. 2018 Sep;834:337–45.
  61. Jiang YC, Wu HM, Cheng KH, Sunny Sun H. Menstrual cycle-dependent febrile episode mediated by sequence-specific repression of poly(ADP-ribose) polymerase-1 on the transcription of the human serotonin receptor 1A gene. Hum Mutat. 2012 Jan;33(1):209–17.
  62. Stam NJ, Roesink C, Dijcks F, Garritsen A, van Herpen A, Olijve W. Human serotonin 5-HT7 receptor: cloning and pharmacological characterisation of two receptor variants. FEBS Lett. 1997 Aug;413(3):489–94.
  63. Oliver E, Rovira E, Montó F, Valldecabres C, Julve R, Muedra V, et al. Beta-adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion. J Hypertens. 2010 Jun;28(6):1281–9.
    External Resources
  64. da Costa Goncalves AC, Fontes MA, Klussmann E, Qadri F, Janke J, Gollasch M, et al. Spinophilin regulates central angiotensin II-mediated effect on blood pressure. J Mol Med (Berl). 2011 Dec;89(12):1219–29.
  65. Sternlicht H, Bakris GL. Blood pressure lowering and sodium-glucose co-transporter 2 inhibitors (SGLT2is): more than osmotic diuresis. Curr Hypertens Rep. 2019 Feb;21(2):12.
  66. Kalstrup T, Blunck R. S4-S5 linker movement during activation and inactivation in voltage-gated K+ channels. Proc Natl Acad Sci USA. 2018 Jul;115(29):E6751–9.
  67. Giudicessi JR, Ye D, Kritzberger CJ, Nesterenko VV, Tester DJ, Antzelevitch C, et al. Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death. Hum Mutat. 2012 Jun;33(6):989–97.
  68. Lazzerini PE, Capecchi PL, Laghi-Pasini F, Boutjdir M. Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias. Nat Rev Cardiol. 2017 Sep;14(9):521–35.
  69. Nava C, Dalle C, Rastetter A, Striano P, de Kovel CG, Nabbout R, et al.; EuroEPINOMICS RES Consortium. De novo mutations in HCN1 cause early infantile epileptic encephalopathy. Nat Genet. 2014 Jun;46(6):640–5.
  70. Dibbens LM, Reid CA, Hodgson B, Thomas EA, Phillips AM, Gazina E, et al. Augmented currents of an HCN2 variant in patients with febrile seizure syndromes. Ann Neurol. 2010 Apr;67(4):542–6.
  71. Campuzano O, Sanchez-Molero O, Mademont-Soler I, Riuró H, Allegue C, Coll M, et al. Rare Titin (TTN) variants in diseases associated with sudden cardiac death. Int J Mol Sci. 2015 Oct;16(10):25773–87.
  72. Nakagami H, Kikuchi Y, Katsuya T, Morishita R, Akasaka H, Saitoh S, et al. Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertension. Hypertens Res. 2007 Dec;30(12):1239–46.
  73. Devalla HD, Gélinas R, Aburawi EH, Beqqali A, Goyette P, Freund C, et al. TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT. EMBO Mol Med. 2016 Dec;8(12):1390–408.
  74. Huang XC, Wang W. Association of MEF2A gene 3'UTR mutations with coronary artery disease. Genet Mol Res. 2015 Sep;14(3):11073–8.
  75. Verhoeven K, De Jonghe P, Van de Putte T, Nelis E, Zwijsen A, Verpoorten N, et al. Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10. Am J Hum Genet. 2003 Oct;73(4):926–32.
  76. Beleoken E, Leh H, Arnoux A, Ducot B, Nogues C, De Martin E, et al. SPRi-based strategy to identify specific biomarkers in systemic lupus erythematosus, rheumatoid arthritis and autoimmune hepatitis. PLoS One. 2013 Dec;8(12):e84600.
  77. Berson A, Barbash S, Shaltiel G, Goll Y, Hanin G, Greenberg DS, et al. Cholinergic-associated loss of hnRNP-A/B in Alzheimer’s disease impairs cortical splicing and cognitive function in mice. EMBO Mol Med. 2012 Aug;4(8):730–42.
  78. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013 Mar;495(7442):467–73.
  79. Baek WY, de Crombrugghe B, Kim JE. Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance. Bone. 2010 Apr;46(4):920–8.
  80. Rogers MA, Edler L, Winter H, Langbein L, Beckmann I, Schweizer J. Characterization of new members of the human type II keratin gene family and a general evaluation of the keratin gene domain on chromosome 12q13.13. J Invest Dermatol. 2005 Mar;124(3):536–44.
  81. Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, McKenna-Yasek D, et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):285–90.
  82. Kim Y, Kim HJ, Cha SJ, Choi HJ, Kim H, Lee S, et al. Genetic activation of parkin rescues TAF15-induced neurotoxicity in a Drosophila model of amyotrophic lateral sclerosis. Neurobiol Aging. 2019 Jan;73:68–73.
  83. Kapeli K, Pratt GA, Vu AQ, Hutt KR, Martinez FJ, Sundararaman B, et al. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat Commun. 2016 Jul;7(1):12143.
  84. Sekiba K, Otsuka M, Ohno M, Kishikawa T, Yamagami M, Suzuki T, et al. DHX9 regulates production of hepatitis B virus-derived circular RNA and viral protein levels. Oncotarget. 2018 Apr;9(30):20953–64.
  85. Wang RR, Pan R, Zhang W, Fu J, Lin JD, Meng ZX. The SWI/SNF chromatin-remodeling factors BAF60a, b, and c in nutrient signaling and metabolic control. Protein Cell. 2018 Feb;9(2):207–15.
  86. Zech M, Lam DD, Francescatto L, Schormair B, Salminen AV, Jochim A, et al. Recessive mutations in the α3 (VI) collagen gene COL6A3 cause early-onset isolated dystonia. Am J Hum Genet. 2015 Jun;96(6):883–93.
  87. Jochim A, Li Y, Zech M, Lam D, Gross N, Koch K, et al. Microstructural white matter abnormalities in patients with COL6A3 mutations (DYT27 dystonia). Parkinsonism Relat Disord. 2018 Jan;46:74–8.
  88. Demir E, Sabatelli P, Allamand V, Ferreiro A, Moghadaszadeh B, Makrelouf M, et al. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet. 2002 Jun;70(6):1446–58.
  89. Lampe AK, Dunn DM, von Niederhausern AC, Hamil C, Aoyagi A, Laval SH, et al. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet. 2005 Feb;42(2):108–20.
  90. Edwards TL, Michels KA, Hartmann KE, Velez Edwards DR. BET1L and TNRC6B associate with uterine fibroid risk among European Americans. Hum Genet. 2013 Aug;132(8):943–53.
  91. Kinter J, Lazzati T, Schmid D, Zeis T, Erne B, Lützelschwab R, et al. An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease. Neurobiol Dis. 2013 Jan;49:221–31.
  92. Lossos A, Elazar N, Lerer I, Schueler-Furman O, Fellig Y, Glick B, et al. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder. Brain. 2015 Sep;138(Pt 9):2521–36.
  93. Vetrugno R, Liguori R, D’Alessandro R, D’Angelo R, Alessandria M, Montagna P. Axial myoclonus in paraproteinemic polyneuropathy. Muscle Nerve. 2008 Oct;38(4):1330–5.
  94. Rose NR. Learning from myocarditis: mimicry, chaos and black holes. F1000Prime Rep. 2014 May;6:25.
  95. Whitton JL, Fujinami RS. Viruses as triggers of autoimmunity: facts and fantasies. Curr Opin Microbiol. 1999 Aug;2(4):392–7.
  96. Crowe W, Allsopp PJ, Watson GE, Magee PJ, Strain JJ, Armstrong DJ, et al. Mercury as an environmental stimulus in the development of autoimmunity - A systematic review. Autoimmun Rev. 2017 Jan;16(1):72–80.
  97. Vatanen T, Kostic AD, d’Hennezel E, Siljander H, Franzosa EA, Yassour M, et al.; DIABIMMUNE Study Group. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell. 2016 May;165(4):842–53.
  98. Zhou Q, Qiu H. The mechanistic impact of N-glycosylation on stability, pharmacokinetics, and immunogenicity of therapeutic proteins. J Pharm Sci. 2019 Apr;108(4):1366–77.
  99. Travers TS, Harlow L, Rosas IO, Gochuico BR, Mikuls TR, Bhattacharya SK, et al. Extensive citrullination promotes immunogenicity of HSP90 through protein unfolding and exposure of cryptic epitopes. J Immunol. 2016 Sep;197(5):1926–36.
  100. Torosantucci R, Sharov VS, van Beers M, Brinks V, Schöneich C, Jiskoot W. Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity. Mol Pharm. 2013 Jun;10(6):2311–22.
  101. Ansari NA, Dash D. Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. Aging Dis. 2013 Feb;4(1):50–6.
    External Resources
  102. Perley CC, Brocato RL, Kwilas SA, Daye S, Moreau A, Nichols DK, et al. Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses. PLoS One. 2019 May;14(5):e0216700.
  103. Poland GA, Whitaker JA, Poland CM, Ovsyannikova IG, Kennedy RB. Vaccinology in the third millennium: scientific and social challenges. Curr Opin Virol. 2016 Apr;17:116–25.
  104. Kanduc D. Immunogenicity, immunopathogenicity, and immunotolerance in one graph. Anticancer Agents Med Chem. 2015;15(10):1264–8.
  105. Qiao J, Zhou G, Ding Y, Zhu D, Fang H. Multiple paraneoplastic syndromes: myasthenia gravis, vitiligo, alopecia areata, and oral lichen planus associated with thymoma. J Neurol Sci. 2011 Sep;308(1-2):177–9.
  106. Kanduc D. The self/nonself issue: A confrontation between proteomes. Self Nonself. 2010 Jul;1(3):255–8.
  107. Ryabkova VA, Shubik YV, Erman MV, Churilov LP, Kanduc D, Shoenfeld Y. Lethal immunoglobulins: autoantibodies and sudden cardiac death. Autoimmun Rev. 2019 Apr;18(4):415–25.
  108. Kanduc D, Shoenfeld Y. From HBV to HPV: designing vaccines for extensive and intensive vaccination campaigns worldwide. Autoimmun Rev. 2016 Nov;15(11):1054–61.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: July 07, 2019
Accepted: August 22, 2019
Published online: October 08, 2019
Issue release date: December 2019

Number of Print Pages: 11
Number of Figures: 2
Number of Tables: 5

ISSN: 1015-2008 (Print)
eISSN: 1423-0291 (Online)

For additional information: https://www.karger.com/PAT

References

  1. Janeway CA Jr., Travers P, Walport M, Shlomchik MJ: Immunobiology: The Immune System in Health and Disease. New York: Garland Science; 2001.
  2. Nielsen PR, Kragstrup TW, Deleuran BW, Benros ME. Infections as risk factor for autoimmune diseases - A nationwide study. J Autoimmun. 2016 Nov;74:176–81.
  3. Honkanen H, Oikarinen S, Nurminen N, Laitinen OH, Huhtala H, Lehtonen J, et al. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia. 2017 Mar;60(3):424–31.
  4. Sakkas LI, Daoussis D, Liossis SN, Bogdanos DP. The infectious basis of ACPA-positive rheumatoid arthritis. Front Microbiol. 2017 Sep;8:1853.
  5. Alaedini A, Lebwohl B, Wormser GP, Green PH, Ludvigsson JF. Borrelia infection and risk of celiac disease. BMC Med. 2017 Sep;15(1):169.
  6. Blackmore S, Hernandez J, Juda M, Ryder E, Freund GG, Johnson RW, et al. Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2017 Jul;114(30):E6107–16.
  7. Kemppainen KM, Lynch KF, Liu E, Lönnrot M, Simell V, Briese T, et al.; TEDDY Study Group. Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life. Clin Gastroenterol Hepatol. 2017 May;15(5):694–702.e5.
  8. Mustonen N, Siljander H, Peet A, Tillmann V, Härkönen T, Ilonen J, et al.; DIABIMMUNE Study Group. Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk. Pediatr Diabetes. 2018 Mar;19(2):293–9.
  9. Burgueño-Montañés C, Álvarez-Coronado M, Colunga-Cueva M. Autoimmune neuroretinopathy secondary to Zika virus infection. Arch Soc Esp Oftalmol. 2018 Jul;93(7):336–41.
  10. Fujinami RS, Oldstone MB, Wroblewska Z, Frankel ME, Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA. 1983 Apr;80(8):2346–50.
  11. Oldstone MB. Molecular mimicry: its evolution from concept to mechanism as a cause of autoimmune diseases. Monoclon Antib Immunodiagn Immunother. 2014 Jun;33(3):158–65.
  12. Natale C, Giannini T, Lucchese A, Kanduc D. Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunol Cell Biol. 2000 Dec;78(6):580–5.
  13. Kanduc D, Stufano A, Lucchese G, Kusalik A. Massive peptide sharing between viral and human proteomes. Peptides. 2008 Oct;29(10):1755–66.
  14. Trost B, Lucchese G, Stufano A, Bickis M, Kusalik A, Kanduc D. No human protein is exempt from bacterial motifs, not even one. Self Nonself. 2010 Oct;1(4):328–34.
  15. Lucchese G, Capone G, Kanduc D. Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins. Schizophr Bull. 2014 Mar;40(2):362–75.
  16. Lucchese G. Understanding neuropsychiatric diseases, analyzing the peptide sharing between infectious agents and the language-associated NMDA 2A protein. Front Psychiatry. 2016 Apr;7:60.
  17. Lucchese G. From toxoplasmosis to schizophrenia via NMDA dysfunction: peptide overlap between Toxoplasma gondii and N-Methyl-d-Aspartate Receptors as a potential mechanistic link. Front Psychiatry. 2017 Mar;8:37.
  18. Kanduc D, Shoenfeld Y. Inter-pathogen peptide sharing and the original antigenic sin: solving a paradox. Open Immunol J. 2018;8(1):11–27.
    External Resources
  19. Cohn M. Two unresolved problems facing models of the Self-Nonself discrimination. J Theor Biol. 2015 Dec;387:31–8.
  20. Rose NR. Negative selection, epitope mimicry and autoimmunity. Curr Opin Immunol. 2017 Dec;49:51–5.
  21. Reddehase MJ, Rothbard JB, Koszinowski UH. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature. 1989 Feb;337(6208):651–3.
  22. Zeng W, Pagnon J, Jackson DC. The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function. Mol Immunol. 2007 Jul;44(15):3724–31.
  23. Kanduc D. Homology, similarity, and identity in peptide epitope immunodefinition. J Pept Sci. 2012 Aug;18(8):487–94.
  24. Kanduc D. Pentapeptides as minimal functional units in cell biology and immunology. Curr Protein Pept Sci. 2013 Mar;14(2):111–20.
  25. Hao SS, Zong MM, Zhang Z, Cai JX, Zheng Y, Feng XL, et al. The inducing roles of the new isolated bursal hexapeptide and pentapeptide on the immune response of AIV vaccine in mice. Protein Pept Lett. 2019;26(7):542–9.
  26. Godi A, Facchetti A, Bissett SL, Cocuzza C, Miller E, Beddows S. Naturally occurring major and minor capsid protein variants of Human Papillomavirus 45 (HPV45): differential recognition by cross-neutralizing antibodies generated by HPV vaccines. J Virol. 2015 Dec;90(6):3247–52.
  27. Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, et al. The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res. 2019 Jan;47(D1):D339–43.
  28. Chen C, Li Z, Huang H, Suzek BE, Wu CH; UniProt Consortium. A fast Peptide Match service for UniProt Knowledgebase. Bioinformatics. 2013 Nov;29(21):2808–9.
  29. UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan;47(D1):D506–15.
  30. Kanduc D. The comparative biochemistry of viruses and humans: an evolutionary path towards autoimmunity. Biol Chem. 2019 Apr;400(5):629–38.
  31. Wood-Trageser MA, Gurbuz F, Yatsenko SA, Jeffries EP, Kotan LD, Surti U, et al. MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability. Am J Hum Genet. 2014 Dec;95(6):754–62.
  32. Guo H, Zhu P, Yan L, Li R, Hu B, Lian Y, et al. The DNA methylation landscape of human early embryos. Nature. 2014 Jul;511(7511):606–10.
  33. Andreu-Vieyra CV, Chen R, Agno JE, Glaser S, Anastassiadis K, Stewart AF, et al. MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing. PLoS Biol. 2010 Aug;8(8):e1000453.
  34. Morimoto A, Shibuya H, Zhu X, Kim J, Ishiguro K, Han M, et al. A conserved KASH domain protein associates with telomeres, SUN1, and dynactin during mammalian meiosis. J Cell Biol. 2012 Jul;198(2):165–72.
  35. Mizusawa Y, Kuji N, Tanaka Y, Tanaka M, Ikeda E, Komatsu S, et al. Expression of human oocyte-specific linker histone protein and its incorporation into sperm chromatin during fertilization. Fertil Steril. 2010 Mar;93(4):1134–41.
  36. Bione S, Sala C, Manzini C, Arrigo G, Zuffardi O, Banfi S, et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet. 1998 Mar;62(3):533–41.
  37. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003 May;72(5):1117–30.
  38. Jääskeläinen M, Nieminen A, Pökkylä RM, Kauppinen M, Liakka A, Heikinheimo M, et al. Regulation of cell death in human fetal and adult ovaries—role of Bok and Bcl-X(L). Mol Cell Endocrinol. 2010 Dec;330(1-2):17–24.
  39. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet. 2004 Jul;75(1):106–11.
  40. Kasippillai T, MacArthur DG, Kirby A, Thomas B, Lambalk CB, Daly MJ, et al. Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency. J Clin Endocrinol Metab. 2013 Sep;98(9):E1534–9.
  41. Martins da Silva SJ, Bayne RA, Cambray N, Hartley PS, McNeilly AS, Anderson RA. Expression of activin subunits and receptors in the developing human ovary: activin A promotes germ cell survival and proliferation before primordial follicle formation. Dev Biol. 2004 Feb;266(2):334–45.
  42. Dam AH, Koscinski I, Kremer JA, Moutou C, Jaeger AS, Oudakker AR, et al. Homozygous mutation in SPATA16 is associated with male infertility in human globozoospermia. Am J Hum Genet. 2007 Oct;81(4):813–20.
  43. Yan W, Ma L, Burns KH, Matzuk MM. HILS1 is a spermatid-specific linker histone H1-like protein implicated in chromatin remodeling during mammalian spermiogenesis. Proc Natl Acad Sci USA. 2003 Sep;100(18):10546–51.
  44. Matsuoka Y, Miyagawa Y, Tokuhiro K, Kitamura K, Iguchi N, Maekawa M, et al. Isolation and characterization of the spermatid-specific Smrp1 gene encoding a novel manchette protein. Mol Reprod Dev. 2008 Jun;75(6):967–75.
  45. Lehti MS, Henriksson H, Rummukainen P, Wang F, Uusitalo-Kylmälä L, Kiviranta R, et al. Cilia-related protein SPEF2 regulates osteoblast differentiation. Sci Rep. 2018 Jan;8(1):859.
  46. Yang YR, Kang DS, Lee C, Seok H, Follo MY, Cocco L, et al. Primary phospholipase C and brain disorders. Adv Biol Regul. 2016 May;61:80–5.
  47. Pang JC, Dong Z, Zhang R, Liu Y, Zhou LF, Chan BW, et al. Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors. Int J Cancer. 2003 May;105(1):76–81.
  48. Andries V, Vandepoele K, Staes K, Berx G, Bogaert P, Van Isterdael G, et al. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest. BMC Cancer. 2015 May;15(1):391.
  49. Kehrer-Sawatzki H, Cooper DN. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes? J Med Genet. 2008 Oct;45(10):622–31.
  50. Kim YO, Nam TS, Park C, Kim SK, Yoon W, Choi SY, et al. Familial pachygyria in both genders related to a DCX mutation. Brain Dev. 2016 Jun;38(6):585–9.
  51. Maliniemi P, Carlsson E, Kaukola A, Ovaska K, Niiranen K, Saksela O, et al. NAV3 copy number changes and target genes in basal and squamous cell cancers. Exp Dermatol. 2011 Nov;20(11):926–31.
  52. Silva JP, Lelianova VG, Ermolyuk YS, Vysokov N, Hitchen PG, Berninghausen O, et al. Latrophilin 1 and its endogenous ligand Lasso/teneurin-2 form a high-affinity transsynaptic receptor pair with signaling capabilities. Proc Natl Acad Sci USA. 2011 Jul;108(29):12113–8.
  53. Li J, Shalev-Benami M, Sando R, Jiang X, Kibrom A, Wang J, et al. Structural basis for teneurin function in circuit-wiring: a toxin motif at the synapse. Cell. 2018 Apr;173(3):735–748.e15.
  54. Ferralli J, Tucker RP, Chiquet-Ehrismann R. The teneurin C-terminal domain possesses nuclease activity and is apoptogenic. Biol Open. 2018 Mar;7(3):bio031765.
  55. Graumann R, Di Capua GA, Oyarzún JE, Vásquez MA, Liao C, Brañes JA, et al. Expression of teneurins is associated with tumor differentiation and patient survival in ovarian cancer. PLoS One. 2017 May;12(5):e0177244.
  56. Tsokos GC, Gordon C, Smolen JS, editors. Systemic Lupus Erythematosus: a Companion to Rheumatology. Philadelphia: Mosby Elsevier; 2007.
  57. Wang B, Shao X, Wang D, Xu D, Zhang JA. Vaccinations and risk of systemic lupus erythematosus and rheumatoid arthritis: A systematic review and meta-analysis. Autoimmun Rev. 2017 Jul;16(7):756–65.
  58. Garg M, Mufti N, Palmore TN, Hasni SA. Recommendations and barriers to vaccination in systemic lupus erythematosus. Autoimmun Rev. 2018 Oct;17(10):990–1001.
  59. Tayebati SK, Lokhandwala MF, Amenta F. Dopamine and vascular dynamics control: present status and future perspectives. Curr Neurovasc Res. 2011 Aug;8(3):246–57.
  60. Martikainen IK, Hagelberg N, Jääskeläinen SK, Hietala J, Pertovaara A. Dopaminergic and serotonergic mechanisms in the modulation of pain: in vivo studies in human brain. Eur J Pharmacol. 2018 Sep;834:337–45.
  61. Jiang YC, Wu HM, Cheng KH, Sunny Sun H. Menstrual cycle-dependent febrile episode mediated by sequence-specific repression of poly(ADP-ribose) polymerase-1 on the transcription of the human serotonin receptor 1A gene. Hum Mutat. 2012 Jan;33(1):209–17.
  62. Stam NJ, Roesink C, Dijcks F, Garritsen A, van Herpen A, Olijve W. Human serotonin 5-HT7 receptor: cloning and pharmacological characterisation of two receptor variants. FEBS Lett. 1997 Aug;413(3):489–94.
  63. Oliver E, Rovira E, Montó F, Valldecabres C, Julve R, Muedra V, et al. Beta-adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion. J Hypertens. 2010 Jun;28(6):1281–9.
    External Resources
  64. da Costa Goncalves AC, Fontes MA, Klussmann E, Qadri F, Janke J, Gollasch M, et al. Spinophilin regulates central angiotensin II-mediated effect on blood pressure. J Mol Med (Berl). 2011 Dec;89(12):1219–29.
  65. Sternlicht H, Bakris GL. Blood pressure lowering and sodium-glucose co-transporter 2 inhibitors (SGLT2is): more than osmotic diuresis. Curr Hypertens Rep. 2019 Feb;21(2):12.
  66. Kalstrup T, Blunck R. S4-S5 linker movement during activation and inactivation in voltage-gated K+ channels. Proc Natl Acad Sci USA. 2018 Jul;115(29):E6751–9.
  67. Giudicessi JR, Ye D, Kritzberger CJ, Nesterenko VV, Tester DJ, Antzelevitch C, et al. Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death. Hum Mutat. 2012 Jun;33(6):989–97.
  68. Lazzerini PE, Capecchi PL, Laghi-Pasini F, Boutjdir M. Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias. Nat Rev Cardiol. 2017 Sep;14(9):521–35.
  69. Nava C, Dalle C, Rastetter A, Striano P, de Kovel CG, Nabbout R, et al.; EuroEPINOMICS RES Consortium. De novo mutations in HCN1 cause early infantile epileptic encephalopathy. Nat Genet. 2014 Jun;46(6):640–5.
  70. Dibbens LM, Reid CA, Hodgson B, Thomas EA, Phillips AM, Gazina E, et al. Augmented currents of an HCN2 variant in patients with febrile seizure syndromes. Ann Neurol. 2010 Apr;67(4):542–6.
  71. Campuzano O, Sanchez-Molero O, Mademont-Soler I, Riuró H, Allegue C, Coll M, et al. Rare Titin (TTN) variants in diseases associated with sudden cardiac death. Int J Mol Sci. 2015 Oct;16(10):25773–87.
  72. Nakagami H, Kikuchi Y, Katsuya T, Morishita R, Akasaka H, Saitoh S, et al. Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertension. Hypertens Res. 2007 Dec;30(12):1239–46.
  73. Devalla HD, Gélinas R, Aburawi EH, Beqqali A, Goyette P, Freund C, et al. TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT. EMBO Mol Med. 2016 Dec;8(12):1390–408.
  74. Huang XC, Wang W. Association of MEF2A gene 3'UTR mutations with coronary artery disease. Genet Mol Res. 2015 Sep;14(3):11073–8.
  75. Verhoeven K, De Jonghe P, Van de Putte T, Nelis E, Zwijsen A, Verpoorten N, et al. Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10. Am J Hum Genet. 2003 Oct;73(4):926–32.
  76. Beleoken E, Leh H, Arnoux A, Ducot B, Nogues C, De Martin E, et al. SPRi-based strategy to identify specific biomarkers in systemic lupus erythematosus, rheumatoid arthritis and autoimmune hepatitis. PLoS One. 2013 Dec;8(12):e84600.
  77. Berson A, Barbash S, Shaltiel G, Goll Y, Hanin G, Greenberg DS, et al. Cholinergic-associated loss of hnRNP-A/B in Alzheimer’s disease impairs cortical splicing and cognitive function in mice. EMBO Mol Med. 2012 Aug;4(8):730–42.
  78. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013 Mar;495(7442):467–73.
  79. Baek WY, de Crombrugghe B, Kim JE. Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance. Bone. 2010 Apr;46(4):920–8.
  80. Rogers MA, Edler L, Winter H, Langbein L, Beckmann I, Schweizer J. Characterization of new members of the human type II keratin gene family and a general evaluation of the keratin gene domain on chromosome 12q13.13. J Invest Dermatol. 2005 Mar;124(3):536–44.
  81. Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, McKenna-Yasek D, et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):285–90.
  82. Kim Y, Kim HJ, Cha SJ, Choi HJ, Kim H, Lee S, et al. Genetic activation of parkin rescues TAF15-induced neurotoxicity in a Drosophila model of amyotrophic lateral sclerosis. Neurobiol Aging. 2019 Jan;73:68–73.
  83. Kapeli K, Pratt GA, Vu AQ, Hutt KR, Martinez FJ, Sundararaman B, et al. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat Commun. 2016 Jul;7(1):12143.
  84. Sekiba K, Otsuka M, Ohno M, Kishikawa T, Yamagami M, Suzuki T, et al. DHX9 regulates production of hepatitis B virus-derived circular RNA and viral protein levels. Oncotarget. 2018 Apr;9(30):20953–64.
  85. Wang RR, Pan R, Zhang W, Fu J, Lin JD, Meng ZX. The SWI/SNF chromatin-remodeling factors BAF60a, b, and c in nutrient signaling and metabolic control. Protein Cell. 2018 Feb;9(2):207–15.
  86. Zech M, Lam DD, Francescatto L, Schormair B, Salminen AV, Jochim A, et al. Recessive mutations in the α3 (VI) collagen gene COL6A3 cause early-onset isolated dystonia. Am J Hum Genet. 2015 Jun;96(6):883–93.
  87. Jochim A, Li Y, Zech M, Lam D, Gross N, Koch K, et al. Microstructural white matter abnormalities in patients with COL6A3 mutations (DYT27 dystonia). Parkinsonism Relat Disord. 2018 Jan;46:74–8.
  88. Demir E, Sabatelli P, Allamand V, Ferreiro A, Moghadaszadeh B, Makrelouf M, et al. Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy. Am J Hum Genet. 2002 Jun;70(6):1446–58.
  89. Lampe AK, Dunn DM, von Niederhausern AC, Hamil C, Aoyagi A, Laval SH, et al. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet. 2005 Feb;42(2):108–20.
  90. Edwards TL, Michels KA, Hartmann KE, Velez Edwards DR. BET1L and TNRC6B associate with uterine fibroid risk among European Americans. Hum Genet. 2013 Aug;132(8):943–53.
  91. Kinter J, Lazzati T, Schmid D, Zeis T, Erne B, Lützelschwab R, et al. An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease. Neurobiol Dis. 2013 Jan;49:221–31.
  92. Lossos A, Elazar N, Lerer I, Schueler-Furman O, Fellig Y, Glick B, et al. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder. Brain. 2015 Sep;138(Pt 9):2521–36.
  93. Vetrugno R, Liguori R, D’Alessandro R, D’Angelo R, Alessandria M, Montagna P. Axial myoclonus in paraproteinemic polyneuropathy. Muscle Nerve. 2008 Oct;38(4):1330–5.
  94. Rose NR. Learning from myocarditis: mimicry, chaos and black holes. F1000Prime Rep. 2014 May;6:25.
  95. Whitton JL, Fujinami RS. Viruses as triggers of autoimmunity: facts and fantasies. Curr Opin Microbiol. 1999 Aug;2(4):392–7.
  96. Crowe W, Allsopp PJ, Watson GE, Magee PJ, Strain JJ, Armstrong DJ, et al. Mercury as an environmental stimulus in the development of autoimmunity - A systematic review. Autoimmun Rev. 2017 Jan;16(1):72–80.
  97. Vatanen T, Kostic AD, d’Hennezel E, Siljander H, Franzosa EA, Yassour M, et al.; DIABIMMUNE Study Group. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell. 2016 May;165(4):842–53.
  98. Zhou Q, Qiu H. The mechanistic impact of N-glycosylation on stability, pharmacokinetics, and immunogenicity of therapeutic proteins. J Pharm Sci. 2019 Apr;108(4):1366–77.
  99. Travers TS, Harlow L, Rosas IO, Gochuico BR, Mikuls TR, Bhattacharya SK, et al. Extensive citrullination promotes immunogenicity of HSP90 through protein unfolding and exposure of cryptic epitopes. J Immunol. 2016 Sep;197(5):1926–36.
  100. Torosantucci R, Sharov VS, van Beers M, Brinks V, Schöneich C, Jiskoot W. Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity. Mol Pharm. 2013 Jun;10(6):2311–22.
  101. Ansari NA, Dash D. Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. Aging Dis. 2013 Feb;4(1):50–6.
    External Resources
  102. Perley CC, Brocato RL, Kwilas SA, Daye S, Moreau A, Nichols DK, et al. Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses. PLoS One. 2019 May;14(5):e0216700.
  103. Poland GA, Whitaker JA, Poland CM, Ovsyannikova IG, Kennedy RB. Vaccinology in the third millennium: scientific and social challenges. Curr Opin Virol. 2016 Apr;17:116–25.
  104. Kanduc D. Immunogenicity, immunopathogenicity, and immunotolerance in one graph. Anticancer Agents Med Chem. 2015;15(10):1264–8.
  105. Qiao J, Zhou G, Ding Y, Zhu D, Fang H. Multiple paraneoplastic syndromes: myasthenia gravis, vitiligo, alopecia areata, and oral lichen planus associated with thymoma. J Neurol Sci. 2011 Sep;308(1-2):177–9.
  106. Kanduc D. The self/nonself issue: A confrontation between proteomes. Self Nonself. 2010 Jul;1(3):255–8.
  107. Ryabkova VA, Shubik YV, Erman MV, Churilov LP, Kanduc D, Shoenfeld Y. Lethal immunoglobulins: autoantibodies and sudden cardiac death. Autoimmun Rev. 2019 Apr;18(4):415–25.
  108. Kanduc D, Shoenfeld Y. From HBV to HPV: designing vaccines for extensive and intensive vaccination campaigns worldwide. Autoimmun Rev. 2016 Nov;15(11):1054–61.
ppt logo Download Images (.pptx)


Figures
Thumbnail
Thumbnail

Tables
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP